Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Evaluation of APR1 Gene Expression in Candida albicans Strains Isolated From Patients With Multiple Sclerosis.
Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).
Do coping strategies mediate the association between Type D personality and quality of life among people with multiple sclerosis?
Decrease in rate of multiple sclerosis-related hospitalizations in Portugal.
Ischemia/reperfusion injury in vascularized tissue allotransplantation: tissue damage and clinical relevance.
Low quality of life and psychological wellbeing contrast with moderate perceived burden in carers of people with severe multiple sclerosis.
The Perceived Deficits Questionnaire: Perception, Deficit, or Distress?
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons.
Cellular and Molecular Mechanisms Underpinning Macrophage Activation during Remyelination.
Dietary salt intake and time to relapse in paediatric multiple sclerosis.
INFLIXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE UVEITIS RESISTANT TO CONVENTIONAL IMMUNOMODULATORY THERAPY.
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.